Congresses and Meetings

Cambridge Technology Showcase: Reducing incidence of falls in the elderly, bringing cheap diagnosis of killer diseases, aid for physios with sophisticated gait analysis, coatings for medical devices to reduce biofilms.

The Radiological Society of North America held its 97th Scientific Assembly and Annual Meeting in Chicago from Sunday, November 27 – Friday, December 2.

The “Innovations in Cardiovascular Interventions (ICI) – From Idea to Reality” meeting will be held on December 4-6, 2011 in Tel-Aviv, Israel.

The tenth running of the Multidisciplinary European Endovascular Therapy (MEET) congress will be held in Rome on December 1st-3rd, at the Crowne Plaza St Peters Hotel.

Biotronik’s thin strut PRO-Kinetic Energy bare metal stent with passive PROBIO coating showed excellent results in a 1,000 patient all-comers registry.

FDA is taking a proactive stance and working with manufacturers to understand the issue of longitudinal compression in next generation Drug-Eluting Stents.

Cohera Medical has announced that it has begun selling its lead product, TissuGlu® Surgical Adhesive, to hospitals and surgeons in three pilot territories in Germany.

The Veith Vascular Symposium is taking place this week from November 16th to 20th in New York.

Heart rhythm records and calls about shocks from a registry of 14,475 patients with wearable defibrillators listed from 2007 through 2009 show 91.6 percent survived one or more episodes of ventricular fibrillation or ventricular tachycardia.

Abiomed announces Symphony™, a new synchronized minimally invasive implantable cardiac assist device.

American Heart Association Clinical Trial Report indicates that Radiofrequency ablation of target heart tissue shows better results than drug therapy in reducing atrial fibrillation.

In the week ahead, from 16 – 19 November 2011, the attention of health and medical care professionals from around the world will once again focus on Düsseldorf, as the world’s largest medical trade fair gets underway.

Results from the COBRA clinical trial presented at TCT2011 show restenosis rate significantly reduced in diabetics when Cryoplasty adopted in SFA Stenting.

Researchers claim Transapical TAVR is “unattractive from a health economic perspective.” compared with femoral approach.

Late breaking clinical trial results from testing of cangrelor, an investigational intravenous antiplatelet, showed patients can be “bridged” from the time that their physicians stop their oral antiplatelet drugs until they undergo cardiac surgery.

The Association of British Healthcare Industries (ABHI) is once again organising the UK Pavilion at MEDICA in partnership with UK Trade and Investment.